Click for best price
Genital Herpes Treatment Drugs Market Size, Share 2023
Genital herpes is a sexually transmitted disease (STD). This STD causes herpetic sores, which are painful blisters (fluid-filled bumps) that can break open and ooze fluid. About 16 percentTrusted Source of people between the ages of 14 and 49 have this STD.
This report aims to provide a comprehensive presentation of the global market for Genital Herpes Treatment Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Genital Herpes Treatment Drugs. This report contains market size and forecasts of Genital Herpes Treatment Drugs in global, including the following market information:
Global Genital Herpes Treatment Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Genital Herpes Treatment Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Acyclovir Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Genital Herpes Treatment Drugs include AstraZeneca, Plc., Apotheca, Inc., Asahi Kasei Pharma Corporation, Carlsbad Technology, Inc., GlaxoSmithkline, Plc., Mylan N.V., Novartis AG., Merck & Co., Inc. and Teva Pharmaceutical Industries Ltd., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Genital Herpes Treatment Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Genital Herpes Treatment Drugs Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Genital Herpes Treatment Drugs Market Segment Percentages, by Type, 2022 (%)
Acyclovir
Famciclovir
Valacyclovir
Global Genital Herpes Treatment Drugs Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Genital Herpes Treatment Drugs Market Segment Percentages, by Application, 2022 (%)
Hospitals
Clinic
Others
Global Genital Herpes Treatment Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Genital Herpes Treatment Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Genital Herpes Treatment Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Genital Herpes Treatment Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
AstraZeneca, Plc.
Apotheca, Inc.
Asahi Kasei Pharma Corporation
Carlsbad Technology, Inc.
GlaxoSmithkline, Plc.
Mylan N.V.
Novartis AG.
Merck & Co., Inc.
Teva Pharmaceutical Industries Ltd.
Zydus Pharmaceuticals, Inc.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Genital Herpes Treatment Drugs, market overview.
Chapter 2: Global Genital Herpes Treatment Drugs market size in revenue.
Chapter 3: Detailed analysis of Genital Herpes Treatment Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Genital Herpes Treatment Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Genital Herpes Treatment Drugs Market, Global Outlook and Forecast 2023-2029 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
66 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Genital Herpes Treatment Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Genital Herpes Treatment Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Genital Herpes Treatment Drugs Overall Market Size
2.1 Global Genital Herpes Treatment Drugs Market Size: 2022 VS 2029
2.2 Global Genital Herpes Treatment Drugs Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Genital Herpes Treatment Drugs Players in Global Market
3.2 Top Global Genital Herpes Treatment Drugs Companies Ranked by Revenue
3.3 Global Genital Herpes Treatment Drugs Revenue by Companies
3.4 Top 3 and Top 5 Genital Herpes Treatment Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Genital Herpes Treatment Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Genital Herpes Treatment Drugs Players in Global Market
3.6.1 List of Global Tier 1 Genital Herpes Treatment Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Genital Herpes Treatment Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Genital Herpes Treatment Drugs Market Size Markets, 2022 & 2029
4.1.2 Acyclovir
4.1.3 Famciclovir
4.1.4 Valacyclovir
4.2 By Type - Global Genital Herpes Treatment Drugs Revenue & Forecasts
4.2.1 By Type - Global Genital Herpes Treatment Drugs Revenue, 2018-2023
4.2.2 By Type - Global Genital Herpes Treatment Drugs Revenue, 2024-2029
4.2.3 By Type - Global Genital Herpes Treatment Drugs Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Genital Herpes Treatment Drugs Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Clinic
5.1.4 Others
5.2 By Application - Global Genital Herpes Treatment Drugs Revenue & Forecasts
5.2.1 By Application - Global Genital Herpes Treatment Drugs Revenue, 2018-2023
5.2.2 By Application - Global Genital Herpes Treatment Drugs Revenue, 2024-2029
5.2.3 By Application - Global Genital Herpes Treatment Drugs Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Genital Herpes Treatment Drugs Market Size, 2022 & 2029
6.2 By Region - Global Genital Herpes Treatment Drugs Revenue & Forecasts
6.2.1 By Region - Global Genital Herpes Treatment Drugs Revenue, 2018-2023
6.2.2 By Region - Global Genital Herpes Treatment Drugs Revenue, 2024-2029
6.2.3 By Region - Global Genital Herpes Treatment Drugs Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Genital Herpes Treatment Drugs Revenue, 2018-2029
6.3.2 US Genital Herpes Treatment Drugs Market Size, 2018-2029
6.3.3 Canada Genital Herpes Treatment Drugs Market Size, 2018-2029
6.3.4 Mexico Genital Herpes Treatment Drugs Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Genital Herpes Treatment Drugs Revenue, 2018-2029
6.4.2 Germany Genital Herpes Treatment Drugs Market Size, 2018-2029
6.4.3 France Genital Herpes Treatment Drugs Market Size, 2018-2029
6.4.4 U.K. Genital Herpes Treatment Drugs Market Size, 2018-2029
6.4.5 Italy Genital Herpes Treatment Drugs Market Size, 2018-2029
6.4.6 Russia Genital Herpes Treatment Drugs Market Size, 2018-2029
6.4.7 Nordic Countries Genital Herpes Treatment Drugs Market Size, 2018-2029
6.4.8 Benelux Genital Herpes Treatment Drugs Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Genital Herpes Treatment Drugs Revenue, 2018-2029
6.5.2 China Genital Herpes Treatment Drugs Market Size, 2018-2029
6.5.3 Japan Genital Herpes Treatment Drugs Market Size, 2018-2029
6.5.4 South Korea Genital Herpes Treatment Drugs Market Size, 2018-2029
6.5.5 Southeast Asia Genital Herpes Treatment Drugs Market Size, 2018-2029
6.5.6 India Genital Herpes Treatment Drugs Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Genital Herpes Treatment Drugs Revenue, 2018-2029
6.6.2 Brazil Genital Herpes Treatment Drugs Market Size, 2018-2029
6.6.3 Argentina Genital Herpes Treatment Drugs Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Genital Herpes Treatment Drugs Revenue, 2018-2029
6.7.2 Turkey Genital Herpes Treatment Drugs Market Size, 2018-2029
6.7.3 Israel Genital Herpes Treatment Drugs Market Size, 2018-2029
6.7.4 Saudi Arabia Genital Herpes Treatment Drugs Market Size, 2018-2029
6.7.5 UAE Genital Herpes Treatment Drugs Market Size, 2018-2029
7 Genital Herpes Treatment Drugs Companies Profiles
7.1 AstraZeneca, Plc.
7.1.1 AstraZeneca, Plc. Company Summary
7.1.2 AstraZeneca, Plc. Business Overview
7.1.3 AstraZeneca, Plc. Genital Herpes Treatment Drugs Major Product Offerings
7.1.4 AstraZeneca, Plc. Genital Herpes Treatment Drugs Revenue in Global Market (2018-2023)
7.1.5 AstraZeneca, Plc. Key News & Latest Developments
7.2 Apotheca, Inc.
7.2.1 Apotheca, Inc. Company Summary
7.2.2 Apotheca, Inc. Business Overview
7.2.3 Apotheca, Inc. Genital Herpes Treatment Drugs Major Product Offerings
7.2.4 Apotheca, Inc. Genital Herpes Treatment Drugs Revenue in Global Market (2018-2023)
7.2.5 Apotheca, Inc. Key News & Latest Developments
7.3 Asahi Kasei Pharma Corporation
7.3.1 Asahi Kasei Pharma Corporation Company Summary
7.3.2 Asahi Kasei Pharma Corporation Business Overview
7.3.3 Asahi Kasei Pharma Corporation Genital Herpes Treatment Drugs Major Product Offerings
7.3.4 Asahi Kasei Pharma Corporation Genital Herpes Treatment Drugs Revenue in Global Market (2018-2023)
7.3.5 Asahi Kasei Pharma Corporation Key News & Latest Developments
7.4 Carlsbad Technology, Inc.
7.4.1 Carlsbad Technology, Inc. Company Summary
7.4.2 Carlsbad Technology, Inc. Business Overview
7.4.3 Carlsbad Technology, Inc. Genital Herpes Treatment Drugs Major Product Offerings
7.4.4 Carlsbad Technology, Inc. Genital Herpes Treatment Drugs Revenue in Global Market (2018-2023)
7.4.5 Carlsbad Technology, Inc. Key News & Latest Developments
7.5 GlaxoSmithkline, Plc.
7.5.1 GlaxoSmithkline, Plc. Company Summary
7.5.2 GlaxoSmithkline, Plc. Business Overview
7.5.3 GlaxoSmithkline, Plc. Genital Herpes Treatment Drugs Major Product Offerings
7.5.4 GlaxoSmithkline, Plc. Genital Herpes Treatment Drugs Revenue in Global Market (2018-2023)
7.5.5 GlaxoSmithkline, Plc. Key News & Latest Developments
7.6 Mylan N.V.
7.6.1 Mylan N.V. Company Summary
7.6.2 Mylan N.V. Business Overview
7.6.3 Mylan N.V. Genital Herpes Treatment Drugs Major Product Offerings
7.6.4 Mylan N.V. Genital Herpes Treatment Drugs Revenue in Global Market (2018-2023)
7.6.5 Mylan N.V. Key News & Latest Developments
7.7 Novartis AG.
7.7.1 Novartis AG. Company Summary
7.7.2 Novartis AG. Business Overview
7.7.3 Novartis AG. Genital Herpes Treatment Drugs Major Product Offerings
7.7.4 Novartis AG. Genital Herpes Treatment Drugs Revenue in Global Market (2018-2023)
7.7.5 Novartis AG. Key News & Latest Developments
7.8 Merck & Co., Inc.
7.8.1 Merck & Co., Inc. Company Summary
7.8.2 Merck & Co., Inc. Business Overview
7.8.3 Merck & Co., Inc. Genital Herpes Treatment Drugs Major Product Offerings
7.8.4 Merck & Co., Inc. Genital Herpes Treatment Drugs Revenue in Global Market (2018-2023)
7.8.5 Merck & Co., Inc. Key News & Latest Developments
7.9 Teva Pharmaceutical Industries Ltd.
7.9.1 Teva Pharmaceutical Industries Ltd. Company Summary
7.9.2 Teva Pharmaceutical Industries Ltd. Business Overview
7.9.3 Teva Pharmaceutical Industries Ltd. Genital Herpes Treatment Drugs Major Product Offerings
7.9.4 Teva Pharmaceutical Industries Ltd. Genital Herpes Treatment Drugs Revenue in Global Market (2018-2023)
7.9.5 Teva Pharmaceutical Industries Ltd. Key News & Latest Developments
7.10 Zydus Pharmaceuticals, Inc.
7.10.1 Zydus Pharmaceuticals, Inc. Company Summary
7.10.2 Zydus Pharmaceuticals, Inc. Business Overview
7.10.3 Zydus Pharmaceuticals, Inc. Genital Herpes Treatment Drugs Major Product Offerings
7.10.4 Zydus Pharmaceuticals, Inc. Genital Herpes Treatment Drugs Revenue in Global Market (2018-2023)
7.10.5 Zydus Pharmaceuticals, Inc. Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Genital Herpes Treatment Drugs Market Opportunities & Trends in Global Market
Table 2. Genital Herpes Treatment Drugs Market Drivers in Global Market
Table 3. Genital Herpes Treatment Drugs Market Restraints in Global Market
Table 4. Key Players of Genital Herpes Treatment Drugs in Global Market
Table 5. Top Genital Herpes Treatment Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Genital Herpes Treatment Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Genital Herpes Treatment Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Genital Herpes Treatment Drugs Product Type
Table 9. List of Global Tier 1 Genital Herpes Treatment Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Genital Herpes Treatment Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Genital Herpes Treatment Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Genital Herpes Treatment Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Genital Herpes Treatment Drugs Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Genital Herpes Treatment Drugs Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Genital Herpes Treatment Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Genital Herpes Treatment Drugs Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Genital Herpes Treatment Drugs Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Genital Herpes Treatment Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Genital Herpes Treatment Drugs Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Genital Herpes Treatment Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Genital Herpes Treatment Drugs Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Genital Herpes Treatment Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Genital Herpes Treatment Drugs Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Genital Herpes Treatment Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Genital Herpes Treatment Drugs Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Genital Herpes Treatment Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Genital Herpes Treatment Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Genital Herpes Treatment Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Genital Herpes Treatment Drugs Revenue, (US$, Mn), 2024-2029
Table 30. AstraZeneca, Plc. Company Summary
Table 31. AstraZeneca, Plc. Genital Herpes Treatment Drugs Product Offerings
Table 32. AstraZeneca, Plc. Genital Herpes Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. AstraZeneca, Plc. Key News & Latest Developments
Table 34. Apotheca, Inc. Company Summary
Table 35. Apotheca, Inc. Genital Herpes Treatment Drugs Product Offerings
Table 36. Apotheca, Inc. Genital Herpes Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. Apotheca, Inc. Key News & Latest Developments
Table 38. Asahi Kasei Pharma Corporation Company Summary
Table 39. Asahi Kasei Pharma Corporation Genital Herpes Treatment Drugs Product Offerings
Table 40. Asahi Kasei Pharma Corporation Genital Herpes Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. Asahi Kasei Pharma Corporation Key News & Latest Developments
Table 42. Carlsbad Technology, Inc. Company Summary
Table 43. Carlsbad Technology, Inc. Genital Herpes Treatment Drugs Product Offerings
Table 44. Carlsbad Technology, Inc. Genital Herpes Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. Carlsbad Technology, Inc. Key News & Latest Developments
Table 46. GlaxoSmithkline, Plc. Company Summary
Table 47. GlaxoSmithkline, Plc. Genital Herpes Treatment Drugs Product Offerings
Table 48. GlaxoSmithkline, Plc. Genital Herpes Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. GlaxoSmithkline, Plc. Key News & Latest Developments
Table 50. Mylan N.V. Company Summary
Table 51. Mylan N.V. Genital Herpes Treatment Drugs Product Offerings
Table 52. Mylan N.V. Genital Herpes Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 53. Mylan N.V. Key News & Latest Developments
Table 54. Novartis AG. Company Summary
Table 55. Novartis AG. Genital Herpes Treatment Drugs Product Offerings
Table 56. Novartis AG. Genital Herpes Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 57. Novartis AG. Key News & Latest Developments
Table 58. Merck & Co., Inc. Company Summary
Table 59. Merck & Co., Inc. Genital Herpes Treatment Drugs Product Offerings
Table 60. Merck & Co., Inc. Genital Herpes Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 61. Merck & Co., Inc. Key News & Latest Developments
Table 62. Teva Pharmaceutical Industries Ltd. Company Summary
Table 63. Teva Pharmaceutical Industries Ltd. Genital Herpes Treatment Drugs Product Offerings
Table 64. Teva Pharmaceutical Industries Ltd. Genital Herpes Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 65. Teva Pharmaceutical Industries Ltd. Key News & Latest Developments
Table 66. Zydus Pharmaceuticals, Inc. Company Summary
Table 67. Zydus Pharmaceuticals, Inc. Genital Herpes Treatment Drugs Product Offerings
Table 68. Zydus Pharmaceuticals, Inc. Genital Herpes Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 69. Zydus Pharmaceuticals, Inc. Key News & Latest Developments
List of Figures
Figure 1. Genital Herpes Treatment Drugs Segment by Type in 2022
Figure 2. Genital Herpes Treatment Drugs Segment by Application in 2022
Figure 3. Global Genital Herpes Treatment Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Genital Herpes Treatment Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Genital Herpes Treatment Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Genital Herpes Treatment Drugs Revenue in 2022
Figure 8. By Type - Global Genital Herpes Treatment Drugs Revenue Market Share, 2018-2029
Figure 9. By Application - Global Genital Herpes Treatment Drugs Revenue Market Share, 2018-2029
Figure 10. By Type - Global Genital Herpes Treatment Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Genital Herpes Treatment Drugs Revenue Market Share, 2018-2029
Figure 12. By Application - Global Genital Herpes Treatment Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Genital Herpes Treatment Drugs Revenue Market Share, 2018-2029
Figure 14. By Region - Global Genital Herpes Treatment Drugs Revenue Market Share, 2018-2029
Figure 15. By Country - North America Genital Herpes Treatment Drugs Revenue Market Share, 2018-2029
Figure 16. US Genital Herpes Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Genital Herpes Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Genital Herpes Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Genital Herpes Treatment Drugs Revenue Market Share, 2018-2029
Figure 20. Germany Genital Herpes Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 21. France Genital Herpes Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Genital Herpes Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Genital Herpes Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Genital Herpes Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Genital Herpes Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Genital Herpes Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Genital Herpes Treatment Drugs Revenue Market Share, 2018-2029
Figure 28. China Genital Herpes Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Genital Herpes Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Genital Herpes Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Genital Herpes Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. India Genital Herpes Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Genital Herpes Treatment Drugs Revenue Market Share, 2018-2029
Figure 34. Brazil Genital Herpes Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Genital Herpes Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Genital Herpes Treatment Drugs Revenue Market Share, 2018-2029
Figure 37. Turkey Genital Herpes Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Genital Herpes Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Genital Herpes Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Genital Herpes Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. AstraZeneca, Plc. Genital Herpes Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Apotheca, Inc. Genital Herpes Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Asahi Kasei Pharma Corporation Genital Herpes Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Carlsbad Technology, Inc. Genital Herpes Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. GlaxoSmithkline, Plc. Genital Herpes Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Mylan N.V. Genital Herpes Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Novartis AG. Genital Herpes Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Merck & Co., Inc. Genital Herpes Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Teva Pharmaceutical Industries Ltd. Genital Herpes Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Zydus Pharmaceuticals, Inc. Genital Herpes Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
